A randomized open-label positive-controlled crossover study of clinical efficacy of different type of inhaler devices for asthmatics with eosinophilic rhinosinusitis
Not Applicable
- Conditions
- asthma with eosinophilic chronic rhinosinusitis
- Registration Number
- JPRN-UMIN000025040
- Lead Sponsor
- Kansai Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. exacerbation within 4 weeks (eg. infection and asthma attack) 2. concomitant disease currently treated (eg. heart diseases, hematologic disorders, respiratory diseases) 3. pregnant patients 4. possibility of lack of examination security.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method evels of fractionated exhaled nitrogen oxide 8 weeks after starting each trial drug administration
- Secondary Outcome Measures
Name Time Method ung function, nasal polyp score and sinus CT score 8 weeks after starting each trial drug administration